Abstract:Sophocarpine is the major pharmacologically active compound of the traditional Chinese herbal medicine Radix Sophorae Subprostratae which has been used in treating hepatitis for years in China. It has been demonstrated that Sophocarpine exerts an activity in immune modulation and significantly decreases the production of inflammatory cytokines. However, the protective effects of Sophocarpine in T cell-dependent immune hepatitis remained unknown. The aim of this study was to determine the protective effects and pharmacological mechanisms of Sophocarpine on Concanavalin A (ConA)-induced hepatitis, an experimental model of T cell-mediated liver injury. BALB/C mice were pretreated with Sophocarpine or Bicyclol for five consecutive days. Thirty minutes after the final administration, the mice were injected with 15 mg.kg(-1) of ConA intravenously. The results indicated that pretreatment with Sophocarpine significantly ameliorated liver inflammation and injury as evidenced by both biochemical and histopathological observations. Moreover, in Sophocarpine-pretreated mice, liver messenger RNA expression levels of chemokines and adhesion molecules, such as macrophage inflammatory protein-1 alpha, CXC chemokine ligand 10, and Intercellular adhesion molecule-1, were markedly reduced. Further studies revealed that Sophocarpine significantly downregulated the expression of T-bet via inhibition of signal transducers and activators of transcription1 (STAT1) activation and overexpression of suppressor of cytokine signaling1, inhibiting the activation of Th1 cells and the expression of Interferon-gamma (IFN-gamma). Altogether, these results suggest new opportunities to use Sophocarpine in the treatment of T cell-mediated liver disease. In summary, Sophocarpine could attenuate ConA-induced liver injury, and the protective effect of Sophocarpine was associated with its inhibition effect of pro-inflammatory cytokines, chemokines, and the IFN-gamma/STAT1 signaling pathway.

Sodium Tanshinone Iia Sulfonate Protects Mice From Cona-Induced Hepatitis Via Inhibiting Nf-Kappa B And Ifn-Gamma/Stat1 Pathways

Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways

Role of Cytokines in Tanshinone IIA Protecting Against Immune-Mediated Liver Injury in Mice Induced by Concanavalin A

The Role of T Lymphocyte Subsets In Tanshinone IIA Against Immunological Liver Injury By Concanavalin-A Induced In Mice

Tetrandrine Protects Mice from Concanavalin A-induced Hepatitis Through Inhibiting NF-κB Activation

Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6/STAT3-interleukin-17 signaling

TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway

Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model

Stephanthraniline A Suppressed CD4(+) T Cell-Mediated Immunological Hepatitis Through Impairing PKCθ Function.

Sophocarpine Protects Mice from Cona-Induced Hepatitis Via Inhibition of the Ifn-Gamma/Stat1 Pathway

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

Immunomodulatory Effect of Schisandrae Oil in Mouse Model of Autoimmune Hepatitis Induced by Concanavalin A

Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis.

TP-58, a Novel Thienopyridine Derivative, Protects Mice from ConcanavalinA-Induced Hepatitis by Suppressing Inflammation

Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.

Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis

Protective Effect of Recombinant Hepatical Stimulator Analogue on Concanavalina A-induced Acute Liver Injury in Mice

Protective effect of galangin in Concanavalin A- induced hepatitis in mice

Vitamin C Exerts Beneficial Hepatoprotection Against Concanavalin A-induced Immunological Hepatic Injury in Mice Through Inhibition of NF-κB Signal Pathway.

Diallyl Trisulfide Protects Against Concanavalin A-induced Acute Liver Injury in Mice by Inhibiting Inflammation, Oxidative Stress and Apoptosis.

Ginsenoside Rg1 Attenuates Concanavalin A-Induced Hepatitis in Mice Through Inhibition of Cytokine Secretion and Lymphocyte Infiltration